TX-ILAND
iland, an award-winning global cloud service provider, today announced it has been selected as the Veeam Impact Cloud & Service Provider Partner of the Year for North America. Veeam® Software is the innovative provider of solutions that deliver Availability for the Always-On Enterprise™. This is the second time that iland has been recognized in this way, after winning the same award in 2015. It follows a very strong year for the company, having achieved 300% year-on-year growth with Veeam solutions in 2017. The Veeam Impact Award recognizes the Veeam Cloud & Service Provider (VCSP) partner that demonstrates the best overall performance in the areas of revenue growth, collaboration with Veeam and proactively selling and promoting Veeam’s solutions and adjacent technologies.
Cloud-based backup and disaster recovery adoption is on the rise. Gartner Inc. predicts that “by 2020, the number of enterprises using public cloud infrastructure as a service (IaaS) as their data center backup destination will double, increasing from 10% at the beginning of 2017”* . iland and Veeam share the same vision of helping businesses achieve the highest levels of availability and business continuity with market-leading cloud backup and disaster recovery solutions.
iland’s success is a result of its first-class support, expert cloud backup and disaster recovery knowledge and commitment to incorporating a Veeam strategy into its business. iland provides Secure Cloud Backup with Veeam Cloud Connect and secure Disaster-Recovery-as-a-Service (DRaaS) with Veeam from its global secure VMware-based cloud platform. Its cloud services offer customers the highest levels of service, security and compliance, with flexible pricing to fit changing business needs along with a proven on boarding methodology that streamlines migration to the cloud. Customers also benefit from the advanced visibility and management capabilities enabled by the integration of Veeam Cloud Connect with the award-winning iland cloud console.
Brian Ussher, President at iland, comments: “We’re delighted to receive this award in recognition of our commitment to delivering exceptional cloud solutions and unparalleled customer service in partnership with Veeam®. Veeam’s technologies are a key component of iland’s resilient Secure Cloud infrastructure. Together, we protect some of the largest and most innovative enterprises with secure and compliant cloud backup and replication services delivered at scale globally.
“We are excited to recognize and honor iland as the Veeam Impact Cloud & Service Provider Partner of the Year for North America,” said Matt Kalmenson, Vice President of Sales and Service Provider Sales, Americas, at Veeam. “As Veeam continues to advance its presence in the cloud by offering the best solutions to ensure availability for virtual, physical, and cloud-based workloads in the hybrid cloud, we rely on the commitment and expertise of our partners extensively. iland exemplifies an ideal Veeam partner in their dedication to our joint customers, constant collaboration, and our shared commitment to delivering availability. We extend our congratulations on our highest achievement award and look forward to continued mutual success in 2018.”
We believe this recognition further validates iland’s industry leading cloud-based backup and disaster recovery services. iland was recognized by Gartner as a Leader in the 2017 “Magic Quadrant for Disaster Recovery as a Service” for the second time.** Additionally, iland has been ranked as a leader twice in Forrester Research Inc.’s 2014 and 2017 report “The Forrester Wave™: Disaster-Recovery-As-A-Service Providers”.
* Gartner, “How to Leverage Public Cloud IaaS for Backup and Recovery,” Pushan Rinnen, 22 August 2017.
** Gartner, “Magic Quadrant for Disaster Recovery as a Service,” Ron Blair, Mark Thomas Jaggers, 19 June 2017.
Gartner Disclaimer
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About iland
iland is a global cloud service provider of secure and compliant hosting for infrastructure (IaaS), disaster recovery (DRaaS), and backup as a service (BaaS). They are recognized by industry analysts as a leader in disaster recovery. The award-winning iland Secure Cloud Console natively combines deep layered security, predictive analytics, and compliance to deliver unmatched visibility and ease of management for all of iland’s cloud services. Headquartered in Houston, Texas and London, UK, iland delivers cloud services from its data centers throughout the Americas, Europe, Australia, and Asia. Learn more at www.iland.com .
Trademarks
All registered trademarks and other trademarks belong to their respective owners.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180228005736/en/
Contact:
iland Media Contact
Michael Bartley
C8 Consulting
+44(0)1189497750
paula@c8consulting.co.uk
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Announces Record and Distribution Dates for Special Cash Dividend30.4.2025 08:00:00 CEST | Press release
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that a special dividend of US$55.00 per common share, as previously announced on April 1, 2025, will be paid in cash to valid holders of SINOVAC’s common shares as of the close of business on May 23, 2025, ET. Such cash dividend is expected to be paid on or about July 9, 2025. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC’s product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected hand-foot-mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalificat
SES: Q1 2025 Results30.4.2025 07:30:00 CEST | Press release
Solid Start to the Year SES S.A. announces financial results for the three months ended 31 March 2025. Revenue of €509 million (-0.5% yoy(1)) and Adjusted EBITDA(2) of €280 million (-0.9% yoy(1)), both growing excl. periodic impact Networks revenue up +8.4% yoy(1) including some periodic impact supported by growth in Government (+13.1% yoy(1)) and Mobility (+8.5% yoy(1)); Media (-10.6% yoy(1)) in-line with expectations €360 million of new business and contract renewals signed in Q1 2025 Net Leverage at 1.2x(3) (including cash & cash equivalents of €3.1 billion(4)) O3b mPOWER satellites 7&8 have reached final orbital position – boosting mPower network capacity and resilience from May FY 2025 financial outlook(5) on track with yoy stable Revenue and broadly stable Adjusted EBITDA re-affirmed Fully funded Intelsat acquisition anticipated to complete in H2 2025 – intention to optimise the combined debt structure On 3 April 2025, AGM approved all company recommended resolutions including pr
Geoswift Launches Visa Direct to Enhance Cross-Border Payment Offers in Over 30 Countries30.4.2025 03:00:00 CEST | Press release
Geoswift announced today the integration of Visa Direct with Geoswift's cross-border payments platform. Visa Direct facilitates payouts to more than 140 countries and territories. The integration will enable payouts in 32 countries and territories, across 13 currencies, covering major markets in Asia Pacific, North America, Europe and Middle East, with plans for more in the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423288249/en/ Bryan Ma, SVP, Head of Geoswift Global Payments, and Swapnil Mhasde, Head of Visa Direct Commercialization and Solutions, Asia Pacific, celebrating the launch in Singapore. Geoswift is a leading provider of cross-border payment services and solutions globally. With over two decades of innovation, it has become a trusted name in B2B, education, eCommerce, remittance, and travel payment use cases. Raymond Qu, Group CEO of Geoswift, stated, "At Geoswift, our vision has always been to del
Logitech Announces Q4 and Full Fiscal Year 2025 Results29.4.2025 22:03:00 CEST | Press release
A Year of Broad-Based Sales Growth, Expanded Market Share and Increased Profitability, Driven by Strategic Priorities SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the fourth quarter and full Fiscal Year 2025 ended March 31, 2025. For Fiscal Year 2025: Sales were $4.55 billion, up 6 percent in US dollars and 7 percent in constant currency, compared to the prior year. GAAP operating income was $655 million, up 11 percent compared to the prior year. Non-GAAP operating income was $775 million, up 11 percent compared to the prior year. GAAP earnings per share (EPS) was $4.13, up 7 percent compared to the prior year. Non-GAAP EPS was $4.84, up 14 percent compared to the prior year. Cash flow from operations was $843 million. The year-ending cash balance was $1.5 billion. The Company returned $797 million of cash to shareholders through its annual dividend payment and share repurchases.
U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene29.4.2025 21:32:00 CEST | Press release
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that the U.S. Patent and Trademark Office (USPTO) rendered a Final Written Decision invalidating all claims of Pharmacyclics LLC’s (Pharmacyclics) U.S. Patent No. 11,672,803 (the ‘803 patent) that were challenged by BeiGene in a post-grant review (PGR) proceeding. On November 1, 2023, BeiGene filed a PGR petition with the USPTO challenging the validity of certain claims of the ‘803 patent, in response to a patent infringement lawsuit Pharmacyclics brought against BeiGene concerning BRUKINSA® (zanubrutinib). On May 1, 2024, the USPTO granted BeiGene’s petition to institute the PGR. The USPTO’s Final Written Decision is appealable by Pharmacyclics. Commenting on the ruling, BeiGene General Counsel Chan Lee said: “We are pleased that the USPTO invalidated all challenged claims of the ‘803 patent. Today’s decision reinforces our belief th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom